Active Ingredient: MIRABEGRON
Proprietary Name: MYRBETRIQ
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N202611
Product Number: 001
Approval Date: Jun 28, 2012
Applicant Holder Full Name: ASTELLAS PHARMA GLOBAL DEVELOPMENT INC
Marketing Status:
Prescription
Patent and Exclusivity Information
